Chakrabarti S K, Denniel C, Malick M A, Bai C
Facultéde Médecine, Universitéde Montréal, Montréal, Québec, H3C 3J7, Canada.
Toxicol Appl Pharmacol. 1998 Jul;151(1):123-34. doi: 10.1006/taap.1998.8414.
Previous studies from our laboratory have shown that mitochondrial dysfunction may be an important early event in S-[(1 and 2)-phenyl-2-hydroxyethyl]cysteine (PHEC)-induced cytotoxicity in isolated rat renal proximal tubules. The present study has therefore examined in more detail PHEC-induced mitochondrial dysfunction, both in vivo and in vitro, using isolated renal cortical mitochondria. Renal cortical mitochondria isolated from PHEC-treated rats in vivo showed depressed effects on the mitochondrial respiration and oxidative phosphorylation in both a dose (0, 250, and 500 micromol/kg iv)- and time (0-24 h)-dependent manner in the presence of both succinate (Site 2) and malate plus alpha-ketoglutarate (Site 1) as respiratory substrates, with initial significant depression occurring as early as 4 h following treatment with 500 micromol PHEC/kg. Similar mitochondrial dysfunctions were observed in vitro in concentration- and time-dependent manners with both respiratory substrates. PHEC also caused a marked dose-dependent inhibition of mitochondrial succinate dehydrogenase and NADH cytochrome c reductase activities both in vivo and in vitro, with initial inhibition occurring as early as 4 h after in vivo administration and 45 min after exposure to PHEC in vitro, while the NADH dehydrogenase activity was not considerably inhibited. The mitochondrial ATPase activity was significantly decreased 4 and 24 h following treatment with PHEC (500 micromol/kg). These results suggest that PHEC exerts its inhibitory effect on the mitochondrial respiration and oxidative phosphorylation through the action on the mitochondrial electron transport chain. PHEC significantly reduced the activity of adenine nucleotide translocase as well as the net uptake of substrates by mitochondria without affecting their efflux within 2-4 h after its injection (500 micromol/kg). On the other hand, significant renal damage, as assessed by morphological study, appeared as early as 24 h following such treatment. The observation of similar effects after both in vivo and in vitro exposures may suggest that the effect on mitochondria may have a pathogenic role in PHEC-induced renal injury in rats. PHEC produces mitochondrial toxicity that results from an inactivation of mitochondrial anionic substrate transporters as well as from an inhibition of activities of adenine nucleotide translocase and dehydrogenases.
我们实验室之前的研究表明,线粒体功能障碍可能是S-[(1和2)-苯基-2-羟乙基]半胱氨酸(PHEC)诱导离体大鼠肾近端小管细胞毒性的一个重要早期事件。因此,本研究使用离体肾皮质线粒体,更详细地研究了PHEC在体内和体外诱导的线粒体功能障碍。从体内经PHEC处理的大鼠分离得到的肾皮质线粒体,在以琥珀酸(位点2)和苹果酸加α-酮戊二酸(位点1)作为呼吸底物时,对线粒体呼吸和氧化磷酸化的抑制作用呈现剂量(0、250和500 μmol/kg静脉注射)和时间(0 - 24小时)依赖性,在用500 μmol PHEC/kg处理后最早4小时就出现了明显的抑制。在体外,使用这两种呼吸底物时,也观察到了类似的浓度和时间依赖性线粒体功能障碍。PHEC在体内和体外还均引起线粒体琥珀酸脱氢酶和NADH细胞色素c还原酶活性明显的剂量依赖性抑制,体内给药后最早4小时、体外暴露于PHEC后45分钟就出现了初始抑制,而NADH脱氢酶活性未受到明显抑制。用PHEC(500 μmol/kg)处理后4小时和24小时,线粒体ATP酶活性显著降低。这些结果表明,PHEC通过作用于线粒体电子传递链,对线粒体呼吸和氧化磷酸化发挥抑制作用。PHEC显著降低了腺嘌呤核苷酸转位酶的活性以及线粒体对底物的净摄取,而在注射(500 μmol/kg)后2 - 4小时内不影响其外流。另一方面,通过形态学研究评估,在这种处理后最早24小时就出现了明显的肾损伤。体内和体外暴露后观察到类似的效应,这可能表明对线粒体的影响在PHEC诱导的大鼠肾损伤中可能具有致病作用。PHEC产生线粒体毒性,这是由线粒体阴离子底物转运体失活以及腺嘌呤核苷酸转位酶和脱氢酶活性受到抑制所致。